DocGo price target lowered to $11 from $13 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on DocGo to $11 from $13 and keeps an Overweight rating on the shares. The price target decrease reflects conservative adjustments to 2024 estimates and new 2024 guidance, the analyst tells investors in a research note. New contract growth in all core customer areas is strong, the firm adds.